granulysin Antibodies

Santa Cruz Biotechnology features a diverse variety of granulysin monoclonal antibodies for research focused on understanding immune system responses. granulysin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Granulysin is a cytolytic protein primarily produced by cytotoxic T cells and natural killer cells, playing a crucial role in the immune response against intracellular pathogens and tumor cells. The protein is involved in the induction of apoptosis in target cells and has been implicated in various inflammatory conditions. Understanding granulysin function is essential for developing therapeutic strategies against infections and cancer. Researchers can utilize granulysin monoclonal antibodies to investigate cellular mechanisms and protein expression patterns in different tissue types. Advanced research techniques supported by granulysin monoclonal antibodies enable detailed analysis of protein localization and interactions. Ongoing studies of granulysin continue to reveal new insights into immune system regulation and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for granulysin research support scientific advancement in immunology and therapeutic development, contributing to breakthroughs in understanding immune system responses.